ArticleBriefings in bioinformatics2026
Cytokine-driven immunogenicity prediction: integrating HLA binding and cytokine induction.
Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Computational Prioritisation of Fish-Derived Antimicrobial Peptides by Integrated Multi-Layer Immunogenicity and Structural Analysis.Probiotics and antimicrobial proteins · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cytokines are central to the immune response, determining whether T-cell activation leads to protective immunity or tolerance. The secretion of key cytokines such as IFN-$\gamma$, IL-2, IL-4, and IL-10 shapes the immune response, influencing its presence, pathways, and magnitude. While most existing computational methods for predicting peptide immunogenicity typically focus on either cytokine induction or histocompatibility complex binding affinity separately, they fail to capture the full complexity of immune activation. In this study, we introduce a two-stage computational framework that integrates both cytokine induction and HLA binding affinity predictions to provide a more comprehensive prediction of peptide immunogenicity. First, we develop machine learning models EpiLAMA-IL to predict cytokine secretion based on peptide and parent protein sequences. These models outperform current state-of-the-art cytokine release prediction methods, achieving ROC AUC from 0.79 up to 0.92 depending on the task. These cytokine scores are then combined with HLA binding affinity predictions and peptide physico-chemical descriptors to develop a composite immunogenicity score prediction model EpiLAMA-IM. This approach bridges the gap between sequence-based antigen presentation and functional immune outcomes, offering improved accuracy in predicting immune responses and achieves MCC 0.47 on the CD4Episcore dataset.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.